Discovery Bioanalysis: Current Challenges and Emerging Opportunities for Biologics Quantification by LC-MS, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the different types of biologics and how to quantify them, and look at case studies that successfully utilized hybrid LBA-LC-MS/MS workflow. Attendees will learn practical tips to overcome the challenges inherent in using LBA-LC-MS/MS surrogate peptide quantification workflows by incorporating well-optimized steps with reliable, readily available reagents.

The gold standard has been ligand binding assays (LBA), but liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is emerging as a promising alternative for biologics quantification.

Over the past 20 years, protein and peptide drug development has evolved considerably and made a significant impact on the biotherapeutic market. This expansion into biologics has pushed pharmaceutical companies and contract research organizations (CROs) to explore new approaches for efficiently quantifying these large molecules to support high throughput, early stage pharmacokinetic (PK) studies. The gold standard has been ligand binding assays (LBA), but liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) is emerging as a promising alternative for biologics quantification.

Especially for compounds in early stages of drug development, LC-MS/MS offers multiple advantages over LBA such as multiplexing capability, higher selectivity, and faster method development. In addition, LC-MS/MS is an attractive alternative at early stages since the availability of specific reagents needed for LBA assays can be limited.

This webinar will highlight current challenges and emerging opportunities for the discovery environment.

Join Salinda Wijeratne, PhD, Staff Scientist I, Discovery Bioanalytical, Covance and Lisa Geisler, PhD, Global Discovery Manager, Bioanalytical Chemistry, Covance in a live webinar on Thursday, November 12, 2020 at 11am EST (4pm GMT/UK).

For more information or to register for this event, visit Discovery Bioanalysis: Current Challenges and Emerging Opportunities for Biologics Quantification by LC-MS.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website